[HTML][HTML] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - mdpi.com
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

Adenosine receptor control of cognition in normal and disease

JF Chen - International review of neurobiology, 2014 - Elsevier
Adenosine and adenosine receptors (ARs) are increasingly recognized as important
therapeutic targets for controlling cognition under normal and disease conditions for its dual …

Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet

JRP Prasanthi, B Dasari, G Marwarha, T Larson… - Free Radical Biology …, 2010 - Elsevier
Cholesterol has been linked to the pathogenesis of sporadic Alzheimer's disease (AD) as a
risk factor increasing β-amyloid (Aβ) and oxidative stress levels. Caffeine has antioxidant …

[HTML][HTML] Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A–D2 receptor heteromerization

K Azdad, D Gall, AS Woods, C Ledent, S Ferré… - …, 2009 - nature.com
Bursting activity of striatal medium spiny neurons results from membrane potential
oscillations between a down-and an upstate that could be regulated by G-protein-coupled …

Caffeine and the dopaminergic system

O Cauli, M Morelli - Behavioural pharmacology, 2005 - journals.lww.com
Caffeine is the most widely consumed psychostimulant substance, being self-administered
throughout a wide range of conditions and present in numerous dietary products. Due to its …

Emerging therapies for Parkinson's disease: from bench to bedside

FI Tarazi, ZT Sahli, M Wolny, SA Mousa - Pharmacology & therapeutics, 2014 - Elsevier
The prevalence of Parkinson's disease (PD) increases with age and is projected to increase
in parallel to the rising average age of the population. The disease can have significant …

Adenosine receptor neurobiology: overview

JF Chen, C Lee, Y Chern - International review of neurobiology, 2014 - Elsevier
Adenosine is a naturally occurring nucleoside that is distributed ubiquitously throughout the
body as a metabolic intermediary. In the brain, adenosine functions as an important …

Adenosine–cannabinoid receptor interactions. Implications for striatal function

S Ferré, C Lluís, Z Justinova, C Quiroz… - British journal of …, 2010 - Wiley Online Library
Adenosine and endocannabinoids are very ubiquitous non‐classical neurotransmitters that
exert a modulatory role on the transmission of other more 'classical'neurotransmitters. In this …

Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders

MR Domenici, A Ferrante, A Martire, V Chiodi… - Pharmacological …, 2019 - Elsevier
Abstract Adenosine A 2A receptor (A 2A R) is a G-protein coupled receptor that regulates
several important functions in the central nervous system. Large amount of preclinical data …

Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine

S Ferré - Journal of Alzheimer's Disease, 2010 - content.iospress.com
Caffeine is the most consumed psychoactive drug in the world. It is a non-selective
adenosine receptor antagonist that in the brain targets mainly adenosine A 1 and A 2A …